Skip to main content
. 2021 Sep 8;6(11):2850–2861. doi: 10.1016/j.ekir.2021.08.028

Table 3.

Estimated willingness to pay for exome sequencing over standard nongenomic investigations, using 2 methods: contingent valuation data and the marginal utility estimates from a published discrete choice experiment.

Willingness to pay (AU$) 95% confidence interval
Contingent valuation exercise
Overall 1400 845–1990
Discrete choice experiment
Pediatric mean 4400 4200–4600
Pediatric median 3700 3300–4100
Adult mean 900 800–1000
Adult median 770 740–800